Sequence Similarity Clusters for the Entities in PDB 1G9N

Entity #1 | Chains: G
ENVELOPE GLYCOPROTEIN GP120 protein, length: 313 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 7 10 3504
95 % 8 11 3661 Flexibility: Low
Max RMSD: 1.9, Avg RMSD: 1.0
PDBFlex
90 % 9 13 3029
70 % 93 200 131
50 % 93 200 155
40 % 93 200 165
30 % 93 203 182
Entity #2 | Chains: C
T-CELL SURFACE GLYCOPROTEIN CD4 protein, length: 185 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 23 40 870
95 % 25 46 822 Flexibility: Low
Max RMSD: 2.4, Avg RMSD: 1.2
PDBFlex
90 % 25 46 854
70 % 25 46 903
50 % 25 46 947
40 % 25 46 978
30 % 25 46 957
Entity #3 | Chains: L
ANTIBODY 17B, LIGHT CHAIN protein, length: 214 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 3 18285
95 % 22 34 1136 Flexibility: Low
Max RMSD: 5.3, Avg RMSD: 1.2
PDBFlex
90 % 588 860 2
70 % 1866 2750 1
50 % 3798 5586 1
40 % 4312 6331 1
30 % 5354 7871 1
Entity #4 | Chains: H
ANTIBODY 17B, HEAVY CHAIN protein, length: 229 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 19 26 1233
95 % 19 26 1476 Flexibility: Low
Max RMSD: 3.9, Avg RMSD: 1.0
PDBFlex
90 % 19 26 1499
70 % 1835 2708 2
50 % 3799 5586 1
40 % 4313 6331 1
30 % 5355 7871 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 6CNW 1 A humanized antibody SD84h 37965
2 4UNU 1 A, B IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
3 3PUC 1 A Titin domain M7 (UNP RESIDUES 33774-33871) 9606 2.7.11.1 | Details
4 1U2H 1 A Aortic preferentially expressed protein 1 residues 15-113 9606
5 5IVN 1 A BC2-nanobody 30538
6 5ACM 1 A, B MCG IG LAMBDA CHAIN V-II REGION MGC 9606
7 5E7B 1 A nanobody nano-L06 9838
8 2P45 2 B ANTIBODY CAB-RN05 9838
9 2X1Q 1 A, B GELSOLIN NANOBODY 9844
10 5U64 1 B VHH-28 9838
11 6APO 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
12 2X1P 1 A, B, C, D GELSOLIN NANOBODY 9844
13 4B41 1 A, B ANTIBODY G7 9844
14 2JJU 1 A, B SIGNAL REGULATORY PROTEIN BETA-1 2 ISOFORMS PRODUCED BY ALTERNATIVE SPLICING. IN THIS ENTRY ISOFORM 1 (O00241-1) IS PRESENT N-TERMINAL ECTODOMAIN, RESIDUES 30-148 9606
15 4NZU 1 L 13PL heavy chain Fab 9606
16 4NZU 2 H 13PL light chain Fab 9606
17 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
18 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
19 5TZM 1 A Obscurin UNP residues 4946-5036 9606 2.7.11.1 | Details
20 5IMM 1 B Nanobody 9835
21 4QYO 1 A Fv fragment(mAb6D8) heavy chain 10090
22 4QYO 2 B Fv fragment(mAb6D8) light chain 10090
23 5NLU 1 A single domain llama antibody Nb36 9844
24 2Q20 1 A, B Vk1 O18/O8 germline light chain variable domain 9606
25 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
26 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
27 1MEX 1 L Fab 29G12 light chain 10090
28 1MEX 2 H Fab 29G12 heavy chain 10090
29 1MQK 1 L antibody 7E2 FV fragment, light chain 10090
30 1MQK 2 H antibody 7E2 FV fragment, heavy chain 10090
31 5IMK 1 B Nanobody 9835
32 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
33 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
34 6CWK 1 A Anti-Ricin antibody 30538
35 6EH4 1 D Human T Cell Receptor Alpha Chain 9606
36 6EH4 2 E Human T Cell Receptor Beta Chain 9606
37 3TPK 1 A Immunoglobulin heavy chain antibody variable domain KW1 9835
38 4BUH 1 A, B CLONE M0418 SCFV 9606
39 4B50 1 A 2H10 LLAMA VHH 9844
40 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
41 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
42 6FR4 1 A TCR 003 alpha chain 9606
43 6FR4 2 B TCR 003 Beta Chain 9606
44 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
45 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
46 6DBA 1 A, B nanobody VHH R303 9838
47 6EH5 1 A Human T Cell Receptor Alpha Chain 9606
48 6EH5 2 B Human T Cell Receptor Beta Chain 9606
49 5YD4 1 A, C, E, G scFv 4B08 10090
50 5YD3 1 A, C, E, G scFv 4B08 10090
51 2XT1 2 B CAMELID VHH 9 30538
52 5UD9 1 H Fab heavy chain 9606
53 5UD9 2 L Light chain 9606
54 4QY8 1 A Fv fragment(mAb6D8) heavy chain 10090
55 4QY8 2 B Fv fragment(mAb6D8) light chain 10090
56 4P48 1 A Antibody scFv 180 9031
57 4UDT 1 A T CELL RECEPTOR ALPHA CHAIN, T-CELL RECEPTOR ALPHA CHAIN C REGION VARIABLE DOMAIN TRAV22, RESIDUES 1-112, CONSTANT DOMAIN TRAC1, RESIDUES 2-95 9606
58 4UDT 2 B PROTEIN TRBV7-9, T-CELL RECEPTOR BETA-2 CHAIN C REGION VARIABLE DOMAIN TRBV7-9, RESIDUES 20-115, CONSTANT DOMAIN TRBC2, RESIDUES 1-129 9606
59 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
60 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
61 5VLV 1 A Single Domain Camelid Nanobody VHH T9 9844
62 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
63 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
64 6FR3 1 A 003 TCR Alpha Chain 9606
65 6FR3 2 B 003 TCR Beta Chain 9606
66 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
67 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
68 5J1S 3 C VHH domain BS-2 30538
69 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
70 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
71 2P49 2 B ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
72 6MEE 1 A, C antibody HEPC74 Heavy Chain 9606
73 6MEE 2 B, D antibody HEPC74 Light Chain 9606
74 2I24 1 N New Antigen Receptor PBLA8 variable domain 7801
75 6BJZ 1 H 5c8 Fab Heavy chain 9606
76 6BJZ 2 L 5c8 Fab Light chain 9606
77 5L6Q 1 A, B H5AL 9606
78 5J1T 3 C VHH domain BS-2 30538
79 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
80 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
81 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
82 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
83 6FR5 1 A TCR HA1.7 specific for FLU epitope PKYVKQNTLKLAT, alpha chain 9606
84 6FR5 2 B TCR HA1.7 specific for FLU epitope PKYVKQNTLKLAT, beta chain 9606
85 4XCF 1 L 4E10 Fab light chain 9606
86 4XCF 2 H 4E10 Fab heavy chain 9606
87 5M13 2 B synthetic Nanobody L2_C06 (a-MBP#2) 32630
88 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
89 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
90 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
91 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
92 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
93 3KNB 1 A Titin titin, C-terminal domain M10, resideus 34253-34350 9606 2.7.11.1 | Details
94 3KNB 2 B Obscurin-like protein 1 obscurin-like 1, N-terminal domain, residues 1-105 9606
95 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
96 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
97 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
98 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
99 5X08 1 H Fab 4E10 Heavy chain 9606
100 5X08 2 L Fab 4E10 Light chain 9606
101 2YZ1 1 A, B Tyrosine-protein phosphatase non-receptor type substrate 1 ligand-binidng domain, Ig-like V-type domain 10090
102 6NB8 1 H S230 antigen-binding (Fab) fragment, heavy chain 9606
103 6NB8 2 L S230 antigen-binding (Fab) fragment, light chain 9606
104 6A76 1 L Light chain of the anti-human Robo1 antibody B5209B Fab 10090
105 6A76 2 H Heavy chain of the anti-human Robo1 antibody B5209B Fab 10090
106 6MEG 1 H antibody HEPC46 Heavy Chain 9606
107 6MEG 2 L antibody HEPC46 Light Chain 9606
108 2X1O 1 A, B GELSOLIN NANOBODY 9844
109 4QGY 1 A, B nanobody n25, VH domain 9844
110 5C2B 1 H scFv 3B4 heavy chain 9606
111 5C2B 2 L 3B4 light chain 9606
112 4WW1 1 A TCR Alpha Chain-TRAV21-TRAJ8 9606
113 4WW1 2 B TCR Beta Chain-TRBV7-8 9606
114 4XAW 1 L 4E10 Fab light chain 9606
115 4XAW 2 H 4E10 Fab heavy chain 9606
116 5VNV 1 A Nb.b201 32630
117 4P49 1 A Antibody scFv B8 9031
118 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
119 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
120 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
121 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
122 5DXW 1 A PD-L1 nanobody 9835
123 2NW2 1 A ELS4 TCR alpha chain 9606
124 2NW2 2 B ELS4 TCR beta chain 9606
125 5UCB 1 H Fab Heavy Chain 9606
126 5UCB 2 L Fab Light Chain 9606
127 3T0W 1 A, B immunoglobulin variable lambda domain 9606
128 2VXV 1 H HUMAN IGG ABT-325 9606
129 2VXV 2 L HUMAN IGG ABT-325 9606
130 4N9O 2 B Nanobody Nb484 Nb484 9844
131 4M3K 2 B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
132 5ACL 1 A MCG IG LAMBDA CHAIN V-II REGION MGC 9606
133 6FRJ 1 H scFv-SM3 Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
134 3T0V 1 A immunoglobulin variable lambda domain 9606
135 4GXV 1 H, I Antibody 1F1, heavy chain 9606
136 4GXV 2 L, M Antibody 1F1, light chain 9606
137 6AT6 1 B T-cell receptor beta variable 28, Human nkt tcr beta chain chimera 9606
138 6AT6 2 A T-cell receptor alpha variable 4, T-cell receptor, sp3.4 alpha chain chimera 9606
139 2VXT 1 H MURINE IGG 125-2H 10090
140 2VXT 3 L MURINE IGG 125-2H 10090
141 1OAQ 1 H HEAVY CHAIN FV, RESIDUES 1-121 10090
142 1OAQ 2 L LIGHT CHAIN FV, RESIDUES 1-120 10090
143 1T2J 1 A M12-Variable Heavy domain 9606
144 1DLF 1 L ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
145 1DLF 2 H ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
146 6DBF 2 B InlB specific VHH R303 9838
147 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
148 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
149 6DBG 2 C, D VHH R303 9838
150 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
151 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
152 2XA3 1 A LLAMA HEAVY CHAIN ANTIBODY D7 VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
153 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
154 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
155 2WP3 1 O OBSCURIN-LIKE PROTEIN 1 IG1, RESIDUES 1-106 9606
156 2WP3 2 T TITIN M10, RESIDUES 34252-34350 9606 2.7.11.1 | Details
157 1OGA 4 D T-CELL RECEPTOR ALPHA CHAIN V REGION CONTAINS ALSO C (CONSTANT) REGION 9606
158 1OGA 5 E T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR, RESIDUES 1-130 9606
159 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
160 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
161 5W24 1 L 5C4 Fab Light Chain 10090
162 5W24 2 H 5C4 Fab Heavy Chain 10090
163 4HPY 1 H CH59 Fab heavy chain 9606
164 4HPY 2 L CH59 Fab light chain 9606
165 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
166 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
167 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
168 5VM6 1 A single domain camelid nanobody VHH T10 9844
169 1RJC 1 A camelid heavy chain antibody VHH DOMAIN, VARIABLE DOMAIN 9838
170 4JG1 1 L Fab light chain 9606
171 4JG1 2 H Fab heavy chain 9606
172 1SQ2 2 N novel antigen receptor 7801
173 6E65 1 L TB31F Fab light chain 9606
174 6E65 2 H TB31F Fab heavy chain 9606
175 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
176 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
177 4KML 2 B Nanobody 9844
178 5VF2 1 A scFv 2D10 10090
179 5I8C 1 A VRC34.01 Fab heavy chain 9606
180 5I8C 2 B VRC34.01 Fab light chain 9606
181 4O5L 1 L Fab F045-092 light chain 9606
182 4O5L 2 H Fab F045-092 heavy chain 9606
183 5MYX 1 A, C Fab c#24 light chain 10090
184 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
185 4Z9K 2 B VHH2(F5) antibody 30538
186 3IFL 1 L 12A11 FAB antibody light chain 10090
187 3IFL 2 H 12A11 FAB antibody heavy chain 10090
188 5WK2 1 L M116 LIGHT CHAIN 9606
189 5WK2 2 H M116 HEAVY CHAIN FD 9606
190 3PP4 1 H GA101 Fab heavy chain 10090
191 3PP4 2 L GA101 Fab light chain 10090
192 3KDM 1 A, L Immunoglobulin light chain 9606
193 3KDM 2 B, H Immunoglobulin heavy chain 9606
194 5NIV 1 A Light chain of 5D3 Fab 10090
195 5NIV 2 B Heavy chain of 5D3 Fab 10090
196 5N4J 1 L LIGHT CHAIN 9606
197 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
198 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
199 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
200 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
201 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
202 5X4G 1 A 6H8 Fab heavy chain 10090
203 5X4G 2 B 6H8 Fab light chain 10090
204 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
205 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
206 1J05 1 A, L anti-CEA mAb T84.66, light chain Fv fragment 10090
207 1J05 2 B, H anti-CEA mAb T84.66, heavy chain Fv fragment 10090
208 4PTU 1 A Antibody pn132p2C05, light chain 9606
209 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
210 4TPR 1 L If kappa light chain 10090
211 4TPR 2 H Fab heavy chain 10090
212 5LMW 1 A Nanobody 9844
213 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
214 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
215 3IFN 1 H 12A11 FAB antibody heavy chain 10090
216 3IFN 2 L 12A11 FAB antibody light chain 10090
217 5U3P 1 H DH511.4 Fab Heavy Chain 9606
218 5U3P 2 L DH511.4 Fab Light Chain 9606
219 6BLA 1 H AMM01 Fab Heavy chain 9606
220 6BLA 2 L AMM01 Fab Light chain 9606
221 5NM0 1 A, B, C, D Nb36 9844
222 4TOY 1 H 35O22 Fab Heavy chain 9606
223 4TOY 2 L 35O22 Fab Light chain 9606
224 6H6Y 2 E, F, G, H Nanobody (VHH) Nano-7 30538
225 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
226 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
227 3NPS 2 B S4 FAB HEAVY CHAIN 9606
228 3NPS 3 C S4 FAB LIGHT CHAIN 9606
229 2RHE 1 A BENCE-JONES PROTEIN RHE (LIGHT CHAIN) 9606
230 5I4F 1 A scFv 2D10 10090
231 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
232 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
233 4QXT 1 A Fv fragment(mAb6D8) heavy chain 10090
234 4QXT 2 B Fv fragment(mAb6D8) light chain 10090
235 5VAA 1 A, B Ig gamma-2A chain C region, A allele UNP residues 107-330 10090
236 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
237 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
238 5WN9 1 H scFv 2D10 9606
239 4WEM 2 B Anti-F4+ETEC bacteria VHH variable region 9844
240 4XC3 1 L 4E10 Fab light chain 9606
241 4XC3 2 H 4E10 Fab heavy chain 9606
242 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
243 4PPT 1 A Engineered single domain VHH antibody 9844
244 3R0M 1 A, B Llama VHH A12 9844
245 4M5Y 1 H, I Fab 5J8 heavy chain 9606
246 4M5Y 2 L, M Fab 5J8 light chain 9606
247 4TQE 1 L If kappa light chain 10090
248 4TQE 2 H Fab heavy chain 10090
249 3ZKQ 2 D XA4813 9844
250 5YY4 1 A scFv 4B08 10090
251 4I13 2 B Protein ca1697 (nanobody) 9844
252 2BNU 1 A T-CELL RECEPTOR ALPHA CHAIN C REGION EXTRACELLULAR DOMAINS, RESIDUES 1-91 9606
253 2BNU 2 B T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR DOMAINS, RESIDUES 1-130 9606
254 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
255 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
256 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
257 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
258 5C2U 1 B Nanobody Nanobody 9838
259 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
260 5VSI 2 L CH1/Ckappa Fab light chain 9606
261 2YXM 1 A Myosin-binding protein C, slow-type I-set domain 9606
262 1XFP 1 A heavy chain antibody VHH domain 9838
263 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
264 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
265 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
266 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
267 5JXA 1 H VRC03 Heavy chain 9606
268 5JXA 2 L VRC03 Light chain 9606
269 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
270 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
271 4POY 1 A VHH-metal 9844
272 1A2Y 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
273 1A2Y 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
274 5M2W 1 A, B Llama nanobody nb8 against TssK from T6SS 9844
275 5NLW 1 A nanobody Nb36 9844
276 3CDC 1 A, B Light Chain Amyloidogenic 9606
277 3CDF 1 A, B, C, D, E, F IMMUNOGLOBULIN LIGHT CHAIN 9606
278 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
279 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
280 3DVI 1 A Amyloidogenic light chain variable domain AL-103 9606
281 3NTC 1 L Fab light chain 10090
282 3NTC 2 H Fab heavy chain 10090
283 2DLF 1 L PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S)-KAPPA (LIGHT CHAIN)) FV FRAGMENT (VL DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
284 2DLF 2 H PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) (HEAVY CHAIN)) FV FRAGMENT (VH DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
285 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
286 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
287 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
288 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
289 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
290 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
291 1ZVH 2 A Immunoglobulin heavy chain antibody variable domain D2-L24 9838
292 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
293 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
294 6BE3 1 H Fab (F598) Heavy Chain 9606
295 6BE3 2 L Fab (F598) Light Chain 9606
296 2X6M 1 A HEAVY CHAIN VARIABLE DOMAIN FROM DROMEDARY ENGINEERED FROM IMMUNISED DROMEDARY 9838
297 6FUN 1 A Huamn F11 T-Cell Receptor alpha chain 9606
298 6FUN 2 B Human F11 T-Cell Receptor beta chain 9606
299 3G9A 2 B Minimizer 9838
300 4NWU 1 H APE1551 Ab Fab heavy chain 9606
301 4NWU 2 L APE1551 Ab Fab light chain 9606
302 1EEQ 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
303 1KGC 1 D T-cell receptor alpha chain 9606
304 1KGC 2 E T-cell receptor beta chain 9606
305 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
306 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
307 6FRC 1 A Human T-Cell Receptor F11 alpha Chain 9606
308 6FRC 2 B Human T-Cell Receptor beta Chain 9606
309 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
310 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
311 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
312 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
313 5EWI 1 H VRC38.01 Heavy Chain 9606
314 5EWI 2 L VRC38.01 Light Chain 9606
315 5E2W 1 L AT8 LIGHT CHAIN 10090
316 5E2W 2 H AT8 HEAVY CHAIN 10090
317 5MYK 1 A Fab c#17 light chain 10090
318 5MYK 2 B Fab c#17 heavy chain 10090
319 6FUQ 1 A Human F11 T-Cell Receptor 9606
320 6FUQ 2 B Human F11 T-Cell Receptor beta chain 9606
321 4NZR 1 H PGT135 heavy chain Fab 9606
322 4NZR 2 L PGT135 light chain Fab 9606
323 5MYO 1 A, C Fab c#6 light chain 10090
324 5MYO 2 B, D Fab c#6 heavy chain 10090
325 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
326 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
327 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
328 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
329 3U79 1 A, B, C, D, E, F, G, H Amyloidogenic immunoglobulin light chain protein AL-103 Y32F Y96F, variable domain 9606
330 5UEL 1 H 354NC102 Fab Heavy Chain 9606
331 5UEL 2 L 354NC102 Fab Light Chain 9606
332 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
333 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
334 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
335 2P43 2 B ANTIBODY CAB-RN05 9838
336 2QHL 1 A, B, C, D, E Novel immune-type receptor 10 Extracellular 7998
337 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
338 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
339 5E2V 1 L AT8 LIGHT CHAIN 10090
340 5E2V 2 H AT8 HEAVY CHAIN 10090
341 4KRN 1 A Nanobody/VHH domain EgA1 9844
342 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
343 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
344 4GFT 2 B Nanobody 9844
345 4TVS 2 a, b VHH Domain BS-1 30538
346 4W6Y 2 B Nanobody NbFedF9 9844
347 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
348 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
349 6EZW 1 B VHH antibody BCD090-M2 9844
350 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
351 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
352 5JUE 1 L light chain of UIC2 Fab 10090
353 5JUE 2 H heavy chain of UIC2 Fab 10090
354 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
355 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
356 1UAC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
357 1UAC 2 H Ig VH,anti-lysozyme 10090
358 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
359 5JR1 1 H 10E8 heavy chain 9606
360 5JR1 2 L 10E8 mature light chain 9606
361 4HEM 2 E, F, G Anti-baseplate TP901-1 Llama vHH 02 9844
362 6CA7 1 L PCT64_13C light chain 9606
363 6CA7 2 H PCT64_13C heavy chain 9606
364 5VF6 1 A single chain variable fragment 9031
365 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
366 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
367 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
368 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
369 6FR9 1 A T-Cell Receptor F11 alpha chain 9606
370 6FR9 2 B T-Cell Receptor F11 beta chain 9606
371 5OB5 2 H fAb Heavy chain 9606
372 5OB5 3 L fAb Light chain 9606
373 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
374 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
375 5I66 1 A 8B6 antibody, heavy chain 10090
376 5I66 2 B 8B6 antibody, light chain 10090
377 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
378 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
379 6BZY 1 H 22D11 Heavy Chain 10090
380 6BZY 2 L 22D11 Light Chain 10090
381 3QQ9 1 C, L 101F LIGHT CHAIN 10090
382 3QQ9 2 D, H 101F HEAVY CHAIN 10090
383 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
384 5TKK 3 L mouse antibody vFP5.01 light chain 10090
385 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
386 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
387 4R3S 1 A FV FRAGMENT(MAB6D8) HEAVY CHAIN 10090
388 4R3S 2 B FV FRAGMENT(MAB6D8) LIGHT CHAIN 10090
389 5W6C 1 H UCA Fab heavy chain 9606
390 5W6C 2 L UCA Fab light chain 9606
391 5M14 2 C, D synthetic Nanobody L2_G11 (a-MBP#2) 32630
392 5I1K 1 L FAB LIGHT CHAIN 9606
393 5I1K 2 H FAB HEAVY CHAIN 9606
394 3OZ9 1 L Fab NC-1 kappa light chain 10090
395 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
396 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
397 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
398 5V7U 1 L CBTAU-22.1 Fab light chain 9606
399 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
400 5UEA 1 A, H Fab Heavy Chain 9606
401 5UEA 3 B, L Fab Light Chain 9606
402 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
403 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
404 1YC7 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33 9838
405 1EEU 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
406 3G5Y 1 A 175 light chain 10090
407 3G5Y 2 B 175 heavy chain 10090
408 5O02 2 C Nanobody (VHH) Nano-4 30538
409 5NMV 1 L Fab light chain 10088
410 5NMV 2 H Fab heavy chain 10088
411 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
412 4N8C 2 L, M Light chain of monoclonal antibody 10090
413 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
414 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
415 4UNV 1 A IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
416 4HGW 1 A Antibody Fab fragment, light chain 10090
417 4HGW 2 B Antibody Fab fragment, heavy chain 10090
418 1NLB 1 L antibody 19D9D6 light chain 10090
419 1NLB 2 H antibody 19D9D6 heavy chain 10090
420 1KXQ 2 E, F, G, H antibody VHH fragment CABAMD9 9838
421 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
422 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
423 3VFG 1 L 3F8 Light Chain 10090
424 3VFG 2 H 3F8 Heavy Chain 10090
425 4X7F 2 C, D Nano-25 Nanobody 30538
426 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
427 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
428 3QRG 1 L Fab light chain 9606
429 3QRG 2 H Fab heavy chain Fd fragment 9606
430 4UT7 1 H BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV HEAVY CHAIN DOMAIN, RESIDUES 1-130 9606
431 4UT7 2 L BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV LIGHT CHAIN DOMAIN, RESIDUES 1-147 9606
432 5M6A 1 A, B, C, D Bence-Jones light chain 9606
433 4LLY 2 B, D light chain Clambda 9606
434 4LGR 2 B Camelid nanobody (VHH3) 30538
435 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
436 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
437 5EZI 1 H Fab c12 heavy chain 9606
438 5EZI 2 L Fab c12 Light chain 9606
439 5U66 2 A IgG1 fc derived from CD4-fc fusion 9606
440 4K23 1 H anti-uPAR antibody, heavy chain 10090
441 4K23 2 L anti-uPAR antibody, light chain 10090
442 5J57 2 B VHH single chain antibody V5E1 30538
443 3NCJ 1 L Fab15 Mut8 light chain 9606
444 3NCJ 2 H Fab15 Mut8 heavy chain 9606
445 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
446 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
447 6BA5 1 A, C, E, G Variable domain of Light Chain, antibody R11 9606
448 6BA5 2 B, D, F, H Variable domain Heavy chain, antibody R11 9606
449 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
450 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
451 5W05 1 L M59 FAB LIGHT CHAIN 10090
452 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
453 1MFA 1 L IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN) 10090
454 1MFA 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090
455 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
456 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
457 5OMM 2 C Nanobody (VHH) Nano-14 30538
458 5E03 1 A CTLA-4 nanobody 9835
459 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
460 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
461 4M61 1 A, C Fab A52 light chain 10090
462 4M61 2 B, D Fab A52 heavy chain 10090
463 5YE3 1 B 2A7D9 VH CH1 chain 10090
464 5YE3 2 A 2A7D9 L chain 10090
465 5LZ0 1 A, B PorM nanobody 9844
466 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
467 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
468 1UM5 1 L Antibody 21H3 L chain 10090
469 1UM5 2 H Antibody 21H3 H chain 10090
470 1KXV 2 C, D CAMELID VHH DOMAIN CAB10 9838
471 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
472 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
473 4NWT 1 L APE1531 Ab Fab light chain 9606
474 4NWT 2 H APE1531 Ab Fab heavy chain 9606
475 6DBE 1 A, B nanobody VHH R303 9844
476 3WHX 1 A mAb Fab H fragment 10090
477 3WHX 2 B mAb Fab L fragment 10090
478 3NA9 1 L Fab15 light chain 9606
479 3NA9 2 H Fab15 heavy chain 9606
480 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
481 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
482 6FUO 1 A Human F11 T-Cell Receptor alpha chain 9606
483 6FUO 2 B Human F11 T-Cell Receptor 9606
484 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
485 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
486 4LRI 1 A, B MSL-109 Light Chain 9606
487 4LRI 2 C, P MSL-109 Heavy Chain 9606
488 2XXC 1 B CAMELID VHH 9 30538
489 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
490 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
491 4JN2 1 A, L anti dabigatran Fab 10090
492 4JN2 2 B, H anti dabigatran Fab 10090
493 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
494 4XBE 2 H 4E10 Fab heavy chain 9606
495 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
496 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
497 6BE2 1 H Fab (F598) Heavy Chain 9606
498 6BE2 2 L Fab (F598) Light Chain 9606
499 3QYC 1 A, B VH domain of IgG molecule 9606
500 4EI6 1 A, C Valpha1 XV19 Type II Natural Killer T cell receptor (mouse variable domain, human constant domain) extracellular domain (SEE REMARK 999) 10090
501 4EI6 2 B, D Vbeta16 XV19 Type II Natural Killer T cell receptor (mouse variable domain, human constant domain) extracellular domain (SEE REMARK 999) 10090
502 4JFZ 1 L Fab light chain 9606
503 4JFZ 2 H Fab heavy chain 9606
504 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
505 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
506 5VAK 2 B Nb914 Nanobody 9844
507 3WIF 1 A mAb Fab H fragment 10090
508 3WIF 2 B mAb Fab L fragment 10090
509 5U6A 1 A Light Chain 9606
510 5U6A 2 B Heavy Chain 9606
511 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
512 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
513 3MBX 1 L X836 LIGHT CHAIN 10090
514 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
515 4OF6 1 A, B Protein SYG-1, isoform b D1, UNP residues 19-129 6239
516 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
517 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
518 2XXM 2 B CAMELID VHH 9 30538
519 6APC 1 H Epididymis luminal protein 214 9606
520 6APC 2 L IGL@ protein 9606
521 6BJ8 3 D TCR 55 alpha chain 9606
522 6BJ8 4 H TCR 55 beta chain 9606
523 5IR3 1 A Ig lambda chain V-VI region AR 9606
524 3QXT 1 A, B Anti-Methotrexate CDR1-3 Graft VHH 9844
525 4HHA 1 A Fab KE5 Fab fragment KE5 9606
526 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
527 4AJ0 1 A, B, C, D GERMINAL LINE LAMBDA 3 3RCW VARIANT VARIABLE DOMAIN VARIANT OF 3RJL2, RESIDUES 1-107 9606
528 6FZQ 1 H scFv-1SM3,scFv-1SM3 10090
529 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
530 4RGO 2 H 14G8 heavy chain Fab 10090
531 4RGO 3 L 14G8 light chain Fab 10090
532 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
533 5GRY 1 A, G diabody 9606
534 5UEK 2 H Fab 12E Heavy Chain 9606
535 5UEK 3 L Fab 12E Light Chain 9606
536 3NAA 1 L Fab15 Mut5 light chain 9606
537 3NAA 2 H Fab15 Mut5 heavy chain 9606
538 6DBD 1 A, B, C, D nanobody VHH R326 9844
539 1Q0X 1 L Fab 9B1, light chain 10090
540 1Q0X 2 H Fab 9B1, heavy chain 10090
541 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
542 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
543 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
544 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
545 5JDS 1 B Nanobody 9835
546 4OB5 1 H 4E10 antibody germline precursor 7 heavy chain Fv 9606
547 4OB5 2 L 4E10 antibody germline precursor 7 light chain Fv 9606
548 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
549 5IK3 2 B, D 1E03 Fab fragment light chain 9606
550 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
551 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
552 5XLI 1 a, b FabL 10090
553 5XLI 2 c, d FabH 10090
554 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
555 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
556 1BWW 1 A, B PROTEIN (IG KAPPA CHAIN V-I REGION REI) IMMUNOGLOBULIN KAPPA LIGHT CHAIN 9606
557 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
558 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
559 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
560 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
561 4WUK 1 H CH65 heavy chain 9606
562 4WUK 2 L CH65 light chain 9606
563 5L8L 2 B New antigen receptor variable domain 168098
564 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
565 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
566 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
567 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
568 1ZVY 1 A Immunoglobulin heavy chain antibody variable domain D3-L11 9838
569 5JOP 1 D, L Fab 14.22 light chain 10090
570 5JOP 2 E, H Fab14.22 heavy chain 10090
571 1U0Q 1 A, B immunoglobulin heavy chain variable domain 9844
572 4HPO 1 H CH58 Fab heavy chain 9606
573 4HPO 2 L CH58 Fab light chain 9606
574 6FUP 1 A Human F11 T-cell Receptor alpha Chain 9606
575 6FUP 2 B Huamn F11 T-Cell Receptor beta chain 9606
576 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
577 5UKN 2 L DH522UCA Fab fragment light chain 9544
578 4AIZ 1 A, C, D V2-17 PROTEIN 9606
579 4AIZ 2 B V2-17 PROTEIN 9606
580 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
581 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
582 5L21 2 B VHH-C2 30538
583 5IT2 1 H heavy chain 9606
584 5IT2 2 L light chain 9606
585 5JIH 1 A, B Ig gamma-1 chain C region Hinge-CH2-CH3, UNP Residues 108-329 9606
586 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
587 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
588 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
589 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
590 2W59 1 A, B IGY FCU3-4 9031
591 5FWO 1 A NANOBODY 9844
592 2V9T 1 A ROUNDABOUT HOMOLOG 1 IG1-2M, RESIDUES 61-166 9606
593 5KVE 2 L ZV-48 Antibody scFv Light Chain 10090
594 5KVE 3 H ZV-48 Antibody scFv Heavy chain 10090
595 1L6X 1 A IMMUNOGLOBULIN GAMMA-1 HEAVY CHAIN CONSTANT REGION Fc Fragment, Residues 119-325 9606
596 4L1H 1 A Ig kappa chain V-I region Rei 9606
597 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
598 5MO3 3 L Fab of monoclonal antibody, light chain 10090
599 1OL0 1 A, B IMMUNOGLOBULIN G VARIABLE HEAVY DOMAIN 9606
600 5GZ0 1 A, C FM329 light chain 1383439
601 5GZ0 2 B, D FM329 heavy chain 1383439
602 6DW2 1 A 6078 Fab light chain 9606
603 6DW2 2 B 6078 Fab heavy chain 9606
604 3B9V 1 A, B, C, D heavy chain variable domain 9606
605 4W2P 1 A, B, C, D Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
606 1VFA 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
607 1VFA 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
608 6BQB 1 L MGG4 Fab light chain 9606
609 6BQB 2 H MGG4 Fab heavy chain 9606
610 4PUB 1 H DX-2930 HEAVY CHAIN 9606
611 4PUB 2 L DX-2930 LIGHT CHAIN 9606
612 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
613 6B14 2 L Light chain of Fab BL3-6S97N 10090
614 5N88 1 A, H VH59 antibody 9606
615 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
616 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
617 5TEZ 4 I TCR F50 alpha chain 9606
618 5TEZ 5 J TCR F50 beta chain 9606
619 2D7T 1 H anti polyhydroxybutyrate antibody Fv, heavy chain residues 1-133 9606
620 2D7T 2 L anti polyhydroxybutyrate antibody Fv, light chain residues 1-110 9606
621 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
622 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
623 5GS3 1 A, H diabody protein 9606
624 3BD3 1 A, B catalytic antibody 10090
625 4DZB 1 A Valpha7.2-Jalpha33 (MAIT T cell receptor) 9606
626 4DZB 2 B Vbeta2 (MAIT T cell receptor) 9606
627 2OTU 1 A, C, E, G Fv light chain variable domain 10090
628 2OTU 2 B, D, F, H Fv heavy chain variable domain 10090
629 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
630 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
631 6APP 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
632 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
633 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
634 5VKD 2 H Fab Heavy Chain 9606
635 5VKD 3 L Fab light chain 9606
636 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
637 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
638 1EFQ 1 A KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
639 5XHG 1 A, C polypeptide(L) 10090
640 5XHG 2 B, D polypeptide(H) 10090
641 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
642 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
643 5L8J 2 B New antigen receptor variable domain 168098
644 3UYR 1 H antibody Fab heavy chain 10090
645 3UYR 2 L antibody Fab light chain 10090
646 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
647 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
648 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
649 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
650 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
651 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
652 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
653 3OAZ 2 K, L Fab 2G12, light chain 9606
654 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
655 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
656 1T6V 2 N, O novel antigen receptor 7801
657 1ZAN 1 L Fab AD11 Light Chain 10116
658 1ZAN 2 H Fab AD11 Heavy Chain 10116
659 4BSV 1 A HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2 IG GAMMA 1 FC DOMAIN, RESIDUES 106-330 9606
660 4BSV 2 B HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2 IG GAMMA 1 FC DOMAIN, RESIDUES 106-330 9606
661 6CJK 1 A, C Immunoglobulin Fab light chain 9986
662 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
663 4N0Y 1 H IGH526 Heavy Chain 9606
664 4N0Y 2 L IGH526 Light Chain 9606
665 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
666 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
667 5MTH 1 A, H antibody Fab heavy chain 10090
668 5MTH 2 B, L antibody Fab light chain 10090
669 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
670 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
671 2E27 1 L anti-ciguatoxin antibody, light chain Fv fragment 10090
672 2E27 2 H anti-ciguatoxin antibody, heavy chain Fv fragment 10090
673 1BEC 1 A 14.3.D T CELL ANTIGEN RECEPTOR 10090
674 1RZF 1 L Fab E51 light chain 9606
675 1RZF 2 H Fab E51 heavy chain 9606
676 4N1C 1 A, B immunoglobulin variable light chain domain 9606
677 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
678 4KTE 2 L GE148 Light Chain Fab 9544
679 5I8O 1 H HMM5 antibody heavy chain 9606
680 5I8O 2 L HMM5 antibody light chain 9606
681 4OUO 1 A anti Bla g 1 scFv 9031
682 4JG0 1 L Fab light chain 9606
683 4JG0 2 H Fab heavy chain 9606
684 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
685 4YGV 2 B, L aDabi-Fab2a light chain 9606
686 5JDJ 1 A, B, C, D, E, F, G, H, I, J, K, L, M, N, O, P Titin 9606 2.7.11.1 | Details
687 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
688 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
689 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
690 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
691 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
692 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
693 3EO0 1 A, C GC-1008 Fab Light Chain 10090
694 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
695 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
696 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
697 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
698 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
699 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
700 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
701 6FUR 1 A, C Human F11 T-Cell Receptor alpha chain 9606
702 6FUR 2 B, D Human F11 T-Cell Receptor 9606
703 4POU 2 B VHH Antibody 9844
704 3B5T 1 A, B, C, D, E Novel immune-type receptor 10 Extracellular fragment 7998
705 1MVF 1 A, B immunoglobulin heavy chain variable region 9838
706 6J5D 2 H antibody heavy chain 10090
707 6J5D 3 L antibody light chain 10090
708 4FQI 3 H antibody CR9114 heavy chain Fab 9606
709 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
710 4JVP 1 A, B Anti-HCV E2 alpaca nanobody D03 30538
711 6FUM 1 A Human F11 T-Cell Receptor alpha chain 9606
712 6FUM 2 B Human F11 T-Cell Receptor beta chain 9606
713 3QSK 2 B Engineered 5 Histidine anti-RNase A Camelid VHH Antibody Domain Variant 9838
714 4AIX 1 A, B, C, D IG LAMBDA CHAIN V-IV REGION BAU 9606
715 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
716 4JHA 2 L D25 light chain 9606
717 6B9Z 1 A Trastuzumab Fab light chain 10090
718 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
719 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
720 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
721 4PTT 1 A Antibody pn132p2C05, light chain 9606
722 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
723 6H70 2 C, D Nanobody (VHH) Nano-62 30538
724 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
725 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
726 4EJ1 2 C, D Nb113 camelid antibody fragment 9844
727 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
728 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
729 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
730 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
731 2P42 2 B, D ANTIBODY CAB-RN05 9838
732 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
733 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
734 6CPH 1 D TCR alpha chain 9606
735 6CPH 2 E TCR beta chain 9606
736 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
737 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
738 5M02 3 G Protein Trav14-1,T-cell receptor alpha chain C region 10090
739 5M02 4 H T-cell receptor beta chain V region C5,T-cell receptor beta-2 chain C region 10090
740 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
741 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
742 4DGV 1 H HCV1 Heavy Chain Fab 9606
743 4DGV 2 L HCV1 Light Chain 9606
744 2JJV 1 A, B SIGNAL-REGULATORY PROTEIN BETA 1. 2 ISOFORMS PRODUCED BY ALTERNATIVE SPLICING. IN THIS ENTRY ISOFORM 1 (O00241-1) IS PRESENT N-TERMINAL ECTODOMAIN, RESIDUES 30-148 9606
745 6C5K 1 A, H IgG1 Fab Heavy Chain 10090
746 6C5K 2 B, L IgG1 Fab Light Chain (Kappa) 10090
747 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
748 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
749 5TH2 1 A, C cetuximab Fab, light chain 10090
750 5TH2 2 B, D cetuximab Fab, heavy chain 10090
751 4W4O 1 A, B Ig gamma-1 chain C region UNP residues 107-330 9606
752 1I8K 1 A EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV LIGHT CHAIN 10090
753 1I8K 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
754 5I8K 1 L HHH1 Fab Light chain 9606
755 5I8K 2 H HHH1 Fab Heavy chain 9606
756 4QLR 1 A, B Llama nanobody n02 VH domain 9844
757 5J56 2 B VHH single chain antibody V1C7 30538
758 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
759 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
760 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
761 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
762 1YNL 1 L Ig gamma light chain 10090
763 1YNL 2 H Ig gamma heavy chain 10090
764 6NRQ 1 A, C Defective proboscis extension response 10, isoform A 7227
765 6NRQ 2 B, D Dpr-interacting protein alpha, isoform A 7227
766 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
767 5EPM 2 B, F Antibody Fab fragment light chain 10090
768 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
769 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
770 5VH5 1 A Infliximab Fc 10090
771 3UMT 1 A scFv heavy chain and light chain 10090
772 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
773 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
774 4NUJ 1 A PGT152 light chain 9606
775 4NUJ 2 B PGT152 heavy chain 9606
776 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
777 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
778 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
779 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
780 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
781 3U2S 2 B, L PG9 light chain 9606
782 4X4Z 1 A, B Herceptin VL domain with F53D mutation 9606
783 3NOI 1 A, B Natural cytotoxicity triggering receptor 3 Extracellular domain (unp residues 18-130) 9606
784 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
785 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
786 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
787 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
788 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
789 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
790 5JII 1 A, B Ig gamma-1 chain C region Hinge-CH2-CH3, UNP Residues 108-329 9606
791 4NUG 1 L PGT151 light chain 9606
792 4NUG 2 H PGT151 heavy chain 9606
793 3IU4 1 H chP3 Fab heavy chain 10090
794 3IU4 2 L chP3 Fab light chain 10090
795 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
796 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
797 6J5F 2 H antibody heavy chain 10090
798 6J5F 3 L antibody light chain 10090
799 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
800 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
801 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
802 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
803 1P7K 1 A, L antibody light chain FAB 10090
804 1P7K 2 B, H antibody heavy chain FAB 10090
805 4NBX 2 B A20.1 VHH 9844
806 1G7J 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
807 1G7J 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
808 3RVV 2 C 4C1 - light chain 10090
809 3RVV 3 D 4C1 - heavy chain 10090
810 4HEP 2 G vHH17 domain 9844
811 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
812 3P0Y 2 H Fab DL11 heavy chain 9606
813 3P0Y 3 L Fab DL11 light chain 9606
814 4NPY 1 A, L germline PGT121 light chain Fab 9606
815 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
816 6ANA 2 H LL2 Fab Heavy Chain 10090
817 6ANA 3 L LL2 Fab Light Chain 10090
818 5IBU 1 B, L 6652 Light Chain 9606
819 5IBU 2 G, H 6652 Heavy Chain 9606
820 6FRA 1 A Human T-Cell Receptor F11 alpha Chain 9606
821 6FRA 2 B Human T-Cell Receptor F11 beta Chain 9606
822 5VPL 2 C 4C1 - LIGHT CHAIN 10090
823 5VPL 3 D 4C1 - HEAVY CHAIN 10090
824 6AOD 1 A FXIa Antibody FAB Light Chain 9606
825 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
826 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
827 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
828 2YPV 2 H FAB 12C1 10090
829 2YPV 3 L FAB 12C1 10090
830 3QXU 1 A, B, C, D Anti-Methotrexate CDR1-3 Graft 9844
831 1PEW 1 A, B Jto2, a LAMBDA-6 TYPE IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN 9606
832 5EDX 1 A, B CD8 alpha antigen UNP RESIDUES 2-115 9823
833 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
834 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
835 4JY5 1 L PGT122 light chain Fab 9606
836 4JY5 2 H PGT122 heavy chain Fab 9606
837 6ELE 1 A, H fAB heavy chain 9606
838 6ELE 2 B, L fAB light chain 9606
839 2AQ2 1 A T-CELL RECEPTOR BETA CHAIN V 10090
840 1VFB 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
841 1VFB 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
842 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
843 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
844 6B5R 1 H CIS42 Fab Heavy chain 9606
845 6B5R 2 L CIS42 Fab Light chain 9606
846 5IML 2 B Nanobody 9835
847 5W38 1 A, B Immunoglobulin heavy constant gamma 3 Fc domain, UNP residues 155-377 9606
848 3NAC 1 L Fab15 Mut7 light chain 9606
849 3NAC 2 H Fab15 Mut7 heavy chain 9606
850 3A6C 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
851 3A6C 2 H IG VH, anti-lysozyme 10090
852 2DQD 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
853 2DQD 2 H Ig VH,anti-lysozyme 10090
854 2JJS 1 A, B TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE SUBSTRATE 1 N-TERMINAL ECTODOMAIN, RESIDUES 31-148 9606
855 1HCV 1 A IMMUNOGLOBULIN G FROM IMMUNIZED LLAMA HEAVY CHAIN VARIABLE DOMAIN FROM LLAMA 9844
856 1WTL 1 A, B BENCE-JONES PROTEIN MCG (LIGHT CHAIN) 9606
857 2I25 1 N, O New Antigen Receptor PBLA8 variable domain 7801
858 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
859 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
860 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
861 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
862 1Q72 1 L Fab M82G2, Light chain 10090
863 1Q72 2 H Fab M82G2, Heavy chain 10090
864 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
865 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
866 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
867 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
868 1G7I 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
869 1G7I 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
870 4YHO 1 H aDabi-Fab3 heavy chain 9606
871 4YHO 2 L aDabi-Fab3 light chain 9606
872 6FZR 1 H scFv-SM3 Special processing instructions: Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
873 2WWK 1 O OBSCURIN-LIKE PROTEIN 1 IG1, RESIDUES 1-106 9606
874 2WWK 2 T TITIN M10, RESIDUES 34252-34350 9606 2.7.11.1 | Details
875 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
876 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
877 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
878 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
879 4DGY 1 H HCV1 Heavy Chain Fab 9606
880 4DGY 2 L HCV1 Light Chain 9606
881 3A67 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
882 3A67 2 H IG VH, anti-lysozyme 10090
883 2APB 1 A T-cell receptor beta chain V 10116
884 2APX 1 A T cell receptor beta chain V 10116
885 1RI8 1 A camelid ANTIBODY HEAVY CHAIN VHH domain, VARIABLE DOMAIN 9838
886 6EH6 1 A Human T Cell Receptor Alpha Chain 9606
887 6EH6 2 B Human T Cell Receptor BetaChain 9606
888 5EN2 1 A GD01 heavy chain 10090
889 5EN2 2 B GD01 light chain 10090
890 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
891 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
892 1J1X 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
893 1J1X 2 H Ig VH,anti-lysozyme 10090
894 5L8K 2 B New antigen receptor variable domain 168098
895 5M2J 2 D Anti-(ED-B) scFV 9606
896 3MXW 2 L 5E1 light chain 9606
897 3MXW 3 H 5E1 heavy chain 9606
898 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
899 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
900 2DQC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
901 2DQC 2 H Ig VH,anti-lysozyme 10090
902 1J1O 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
903 1J1O 2 H Ig VH,anti-lysozyme 10090
904 1TVD 1 A, B T CELL RECEPTOR DELTA CHAIN, VARIABLE DOMAIN 9606
905 3EO9 1 L Efalizumab Fab fragment, light chain 9606
906 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
907 1MVU 1 A Ig kappa-chain VJ-region (Light chain) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
908 1MVU 2 B Ig VDJ-region (HEAVY CHAIN) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
909 4M62 1 L, M GEP2 FV light chain UNP residues 21-129 9606
910 4M62 2 H, I GEP2 FV heavy chain 9606
911 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
912 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
913 5IVO 1 A BC2-nanobody 30538
914 1J1P 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
915 1J1P 2 H Ig VH,anti-lysozyme 10090
916 6N35 1 K, L Fab 2G12 light chain 9606
917 6N35 2 H, M Fab 2G12 heavy chain 9606
918 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
919 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
920 4NBZ 2 B, D A26.8 VHH 9844
921 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
922 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090